Mitochondria-targeting aromatic-cationic tetrapeptide; generic name elamipretide
PRODUCT PROFILE
SS-31 (Elamipretide)
£29.99
SS-31 (Elamipretide) is mitochondria-targeting aromatic-cationic tetrapeptide; generic name elamipretide. Researchers examine it in relation to cardiolipin, oxidative phosphorylation and mitochondrial-disease outcomes.
Directly targets mitochondrial membrane cardiolipin, unlike MOTS-c’s signalling-peptide role.
- Evidence stageClinical research
- AvailabilityUnavailable
- Batch recordOpen COA
- DispatchConfirmed at checkout
Out of stock
Ask about availabilitySUGGESTED ADD-ONS
Useful additions, clearly shown.
Suggestions are organised by vial format and catalogue context. They are not combined-use guidance or personal-use advice.
-
Specification review

Bacteriostatic Water
Price range: £4.49 through £8.9910 mL | 3 mLBatch file pendingA laboratory supply with two volume variants, not a peptide or biologically active comparison material.
Available · select size for stockAdd to basket This product has multiple variants. The options may be chosen on the product page -
Preclinical

BPC-157
£32.99Batch COA availableBPC-157 is mainly discussed around stomach and local tissue-repair models. TB-500 is instead studied for actin, cell movement…
Available · 30 in stockAdd to basket -
Preclinical

TB-500
£32.99Batch COA availableTB-500 is discussed as a fragment-like repair material, while thymosin beta-4 is the full natural protein and BPC-157…
Available · 30 in stockAdd to basket
PRODUCT INFORMATION
Clear first. Detailed when needed.
What this material is+
SS-31 (Elamipretide) is mitochondria-targeting aromatic-cationic tetrapeptide; generic name elamipretide. Researchers examine it in relation to cardiolipin, oxidative phosphorylation and mitochondrial-disease outcomes.
Research focus+
Researchers study whether it can protect mitochondrial membranes and improve how cells make energy. Human trials exist, but benefits vary by condition and it remains investigational in many settings.
How the mechanism differs+
Concentrates at the inner mitochondrial membrane and interacts with cardiolipin to influence electron transport and membrane stability.
Evidence and limitations+
Multiple human trials exist, including mixed or unmet primary endpoints; development remains condition-specific.
Testing and batch documentation+
Verified batch documents are available for review.
RESEARCH PROFILE
Understand the distinction.
Researchers study whether it can protect mitochondrial membranes and improve how cells make energy. Human trials exist, but benefits vary by condition and it remains investigational in many settings.
Concentrates at the inner mitochondrial membrane and interacts with cardiolipin to influence electron transport and membrane stability.
Directly targets mitochondrial membrane cardiolipin, unlike MOTS-c’s signalling-peptide role.
Multiple human trials exist, including mixed or unmet primary endpoints; development remains condition-specific.
Educational research context only. This information is not dosage, administration or personal-use guidance.



